Publications by authors named "Regina Swift"

Claim this Profile
S
Serum B-Cell Maturation Antigen as a Biomarker for Predicting Outcomes and Monitoring Patients With Waldenström Macroglobulinemia.
Marissa-Skye Goldwater, Jonathan Moore, Sean Bujarski, Ryan Danis, Zakir Khan, Regina Swift

Eur J Haematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes for unselected, newly diagnosed multiple myeloma patients.
Jonathan T Moore, Sarah M Mettias, Jamie Cheung, Regina Swift, Benjamin Eades

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum B-Cell Maturation Antigen Reflects Disease Status in a Patient Who Developed Nonsecretory Multiple Myeloma: A Case Report.
Ryan Danis, Bernard Regidor, Sean Bujarski, Scott Jew, Marissa-Skye Goldwater, Regina Swift

Case Rep Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone.
James R Berenson, Andrea Limon, Stephanie Rice, Tahmineh Safaie, Ralph Boccia, Regina Swift

Target Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence of translocation t(11;14) among patients with multiple myeloma in a single clinic.
Scott Jew, Marissa-Skye Goldwater, Sean Bujarski, Bernard Regidor, Marsiye Emamy-Sadr, Regina Swift

Am J Clin Pathol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of isatuximab in combination with steroids for the treatment of relapsed/refractory multiple myeloma patients exhibiting only biochemical progression-A single center retrospective study.
Bernard Sean Regidor, Scott Jew, Marissa-Skye Goldwater, Bethany Marie Beatty, Sean Bujarski, Regina Swift

Eur J Haematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients.
Scott Jew, Sean Bujarski, Bernard Regidor, Marsiye Emamy-Sadr, Regina Swift

Target Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of anti-spike antibodies following mRNA vaccination for COVID-19 among patients with multiple myeloma.
Samuel D Stampfer, Sean Bujarski, Marissa-Skye Goldwater, Scott Jew, Bernard Regidor, Regina Swift

Cancer Rep (Hoboken)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma.
James R Berenson, Daisy Martinez, Tahmineh Safaie, Ralph Boccia, Honghao Yang, Regina Swift

Br J Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of venetoclax plus anti-CD38 monoclonal antibody-containing therapies among t(11;14) positive multiple myeloma patients regardless of timing of prior treatment with this antibody.
Bernard Sean Regidor, Dilawer Siddiqi, Bethany Marie Beatty, Marissa-Skye Goldwater, Scott Jew, Regina Swift

Eur J Haematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patients.
James R Berenson, Clara Kim, Sean Bujarski, Jennifer To, Tanya M Spektor, Regina A Swift

Hematol Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen.
Jonathan Afari, Tanya M Spektor, Carley Turner, Alexa Cohen, Alberto Bessudo, Regina A Swift

Exp Hematol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1/2 study of ixazomib in place of bortezomib or carfilzomib in a subsequent line of therapy for patients with multiple myeloma refractory to their last bortezomib or carfilzomib combination regimen.
David Daniely, Eli Forouzan, Tanya M Spektor, Alexa Cohen, Jacob D Bitran, Regina A Swift

Exp Hematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial of the efficacy and safety of elotuzumab in combination with pomalidomide, carfilzomib and dexamethasone for high-risk relapsed/refractory multiple myeloma.
David Yashar, Tanya M Spektor, Daisy Martinez, Matthew Ghermezi, Regina A Swift

Leuk Lymphoma· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of serum B-cell maturation antigen levels to predict outcomes for myeloma patients treated with ruxolitinib, lenalidomide and methylprednisolone.
Sean Bujarski, Christine Sutanto, Tanya M Spektor, Jennifer To, Regina A Swift

Hematol Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination.
Samuel D Stampfer, Marissa-Skye Goldwater, Sean Bujarski, Bernard Regidor, Wenjuan Zhang, Regina Swift

Clin Infect Pract· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to mRNA vaccination for COVID-19 among patients with multiple myeloma.
Samuel D Stampfer, Marissa-Skye Goldwater, Scott Jew, Sean Bujarski, Bernard Regidor, Regina Swift

Leukemia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline serum B-cell maturation antigen levels predict time to disease progression for patients with smoldering multiple myeloma.
Sean Bujarski, Marissa-Skye Goldwater, Bernard Sean Regidor, Scott Jew, David Daniely, Regina A Swift

Eur J Haematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low dose venetoclax in combination with bortezomib, daratumumab, and dexamethasone for the treatment of relapsed/refractory multiple myeloma patients-a single-center retrospective study.
Bernard Regidor, Marissa-Skye Goldwater, Jessica Wang, Sean Bujarski, Regina Swift

Ann Hematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and Changes in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Patients with Relapsed/Refractory Multiple Myeloma Starting New Therapy.
Sean Bujarski, Kyle Udd, Camilia Soof, Haiming Chen, Tanya M Spektor, Regina Swift

Target Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent occurrence of hypophosphatemia among multiple myeloma patients treated with elotuzumab: a single clinic retrospective study.
Bernard Regidor, Regina Swift, Benjamin Eades, Marsiye Emamy-Sadr, Fadi Tarhini

Ann Hematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normalization of serum B-cell maturation antigen levels predicts overall survival among multiple myeloma patients starting treatment.
Scott Jew, Tiffany Chang, Sean Bujarski, Camilia Soof, Haiming Chen, Regina Swift

Br J Haematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment With Elotuzumab in Combination With Dexamethasone Achieves a Complete Remission in a Previously Treated Patient With Multiple Myeloma: A Case Report.
Sydney Meyers, Chace Henning, Regina Swift, Benjamin Eades, Tanya M Spektor

Clin Lymphoma Myeloma Leuk· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Removal of a Silicone Gel Breast Implant in a Multiple Myeloma Patient Improved Disease Status: A Case Report.
Chace Henning, James Wang, Regina Swift, Benjamin Eades, Tanya M Spektor

Case Rep Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Topical Use Crisaborole 2% Ointment for Treatment of Necrobiotic Xanthogranuloma Associated With Multiple Myeloma.
Chace Henning, Sydney Meyers, Regina Swift, Benjamin Eades, Letantia Bussell

Clin Lymphoma Myeloma Leuk· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis